The rise of the rats: A growing paediatric issue

Karine Khatchadourian1, Philippe Ovetchkine, Philippe Minodier

  • 1Division of Infectious Diseases, Department of Paediatrics, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montreal, Quebec.

Insights

Rat bite fever (RBF) is a serious infection from rats. Increased pet rat ownership in children necessitates greater pediatrician awareness of RBF symptoms and risks.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pediatrics

Background:

  • Rat bite fever (RBF) is a bacterial infection caused by Streptobacillus moniliformis or Spirillum minus.
  • RBF presents with fever, arthralgias, and a characteristic rash, and has a significant untreated mortality rate (7-10%).
  • Recent trends show increased popularity of pet rats, particularly among children, raising public health concerns.

Observation:

  • This report details a culture-confirmed case of RBF.
  • Two additional suspected cases of RBF in children are also presented.
  • The cases highlight the ongoing relevance of RBF in pediatric populations.

Findings:

  • The study confirms the occurrence of RBF in Canada.
  • It underscores the association between pet rat ownership and RBF transmission.
  • The findings emphasize the need for vigilance in diagnosing RBF in children.

Implications:

  • Pediatricians must maintain a high index of suspicion for RBF in children, especially those with potential rat exposure.
  • Early diagnosis and treatment of RBF are crucial to prevent severe complications and mortality.
  • Public health awareness regarding the risks of RBF from pet rats should be enhanced.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...